23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Me just dropped some major news in a tough year for the genetic testing company. After months of financial challenges, data ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

and 23andMe has run out of runway: Substantial Doubt: Tuesday marked the fifth round of layoffs since the start of 2023, when ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

CNN confirmed the news of 23andMe’s latest shakeup, as the genetic testing firm has faced multiple internal disputes in the past year. Regarding its workforce reduction, which will total 200 employees ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...